Nucleic Acid Extraction System Market

Nucleic Acid Extraction System Market By Product (DNA Extraction, RNA Extraction, Protein Extraction), By Application (Hospitals & Diagnostic Centers, Life Science, Pharmaceuticals, Academic, Medical & Clinical Research) & Region - Global Market Insights 2022 to 2032

Analysis of Nucleic Acid Extraction System market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Nucleic Acid Extraction System Market Outlook (2022-2032)

Expanding at a stellar CAGR of 11.4%, the global nucleic acid extraction system market is projected to increase from a market valuation of US$ 4.63 billion in 2022 to US$ 13.64 billion by the end of 2032.

Growing demand for nucleic acid extraction systems in hospitals & diagnostic centers is attributed to rising research initiatives, use of nucleic acid testing in molecular diagnostics, and high requirement for rapid and precise disease diagnosis.

Report Attributes


Nucleic Acid Extraction System Market Size (2022)

US$ 4.63 Billion

Projected Market Value (2032)

US$ 13.64 Billion

Global Market Growth Rate (2022-2032)

11.4% CAGR

Market Share of Top 3 Countries (2022)


Key Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Tecan Group AG.
  • Sigma Aldrich Corp.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • PerkinElmer, Inc.
  • F. Hoffmann-La Roche
  • DiaSorin S.p.A

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Sales Analysis of Nucleic Acid Extraction Systems (2017-2021) Vs. Market Outlook (2022-2032)

“Rising Penetration of Automatic Nucleic Acid Extraction Systems in Diverse Sectors”

According to Fact.MR, a market research and competitive intelligence provider, worldwide sales of nucleic acid extraction systems are projected to rise at a CAGR of 11.4% from 2022 to 2032.

Nucleic acid isolation and purification are among the basic tests in molecular laboratory research, with the availability of a wide range of equipment and processes used for its extraction.

Nucleic acid extraction methods are witnessing increasing demand owing to their potential in customized medication. These benefits are expected to drive the growth in the nucleic acid isolation and purification market over the coming years.

The growing penetration of automatic processes in R&D has increased the need for technologically advanced automatic nucleic acid extraction systems. Automated nucleic acid extraction systems are a viable option over manual variants as they offer clear and more precise extraction of nucleic acid in lesser time.

With the ability to run several processes simultaneously with a minimal error ratio, the adoption of nucleic acid purification systems is likely to grow. Such benefits are further projected to fuel gains in the nucleic acid extraction system market.

Growing applications of automatic nucleic acid extraction systems in diverse sectors, such as molecular biology, environmental research, drug delivery, pathology, and forensic science are creating opportunities for stakeholders.

These systems can extract nucleic acid from distinct samples, such as cell culture, serum, and tissue, which is expected to accelerate growth in the global nucleic acid extraction devices market over the coming years.

Nucleic acid extraction system market forecast by Fact.MR

How is Nucleic Acid Extraction System Demand Shaping Up?

“Market Driven by Technological Advancements in Analytical Instruments”

Developments in processes associated with nucleic acid extraction have resulted in increasing demand for quality reagents, kits, and related products. Several companies with product offerings have developed in-house capabilities to generate high-quality products with short turnaround times to meet varying research requirements.

Technological developments in sample preparation methods for nucleic acid extraction, agreements between top research institutes to boost research activities related to molecular biology, increasing demand for custom nucleic acids, and technological advancements in analytical instruments are some of the major drivers for the nucleic acid purification market.

In addition, growing investments in medical research, especially by academic and research institutes over the past several decades have resulted in a better understanding of fundamental pathways with which various proteins involved in the development of disease are either down-regulated or up-regulated.

Over the past several years, the complexity of products by researchers has grown. This is an indication of the enhancement in the understanding of elementary pathways and the discovery of new pathways. Manufacturers must keep up with the latest research developments to cater to the ever-changing needs of life science research.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What Techniques & Strategies are New Companies Resorting To?

“Start-ups Focusing on Introduction of Automated Nucleic Acid Extraction Instruments for Complex Research”

New start-ups have started pushing more resources into developing in-house manufacturing capabilities to generate high-quality products in short durations to meet the increasingly diverse and complex research requirements across different industries surrounding nucleic acid research.

New companies in the industry are introducing total nucleic acid extraction kits and brand-new, automated techniques for nucleic acid extraction.

For instance :

  • QIAGEN N.V. introduced the QIAcube Connect MDx, an automated sample screening and assessment system for molecular diagnostic centers.
  • The Ionic FFPE Complete Purification Kit was introduced by Purigen Biosystems, Inc. to retrieve RNA/DNA from FFPE tissue samples in a single procedure. In comparison to the manual column or bead-based methods, it reduces hands-on time by roughly 75%, which aids in streamlining the operation.

Which Regions Should Nucleic Acid Extraction System Providers Focus On?

“Europe & North America Leading with Presence of Major Biotech Firms & Advancements in Technologies for Analysis of Pharmaceuticals”

Europe accounts for 28.6% share of the global nucleic acid extraction system market. In Europe, major biotech firms are undergoing commercialization and scale-up of operations that are anticipated to boost the market for nucleic acid extraction systems.

North America has a major contribution in driving the overall nucleic acid extraction system market with 24.7% share. The U.S. has reflected rapid advancements in technologies and has stringent standards for the analysis of pharmaceuticals. This is anticipated to propel the growth of the nucleic acid extraction system market in the region.

The market in Asia Pacific is also expected to emerge as one of the leading contributors of revenue to the market, thanks to a thriving medical R&D industry.

Why is There High Demand for Nucleic Acid Extraction Systems from Hospitals & Diagnostic Centers?

“Rapid Deployment of Advanced DNA/RNA Extraction Methods in Hospitals & Diagnostic Centers

Based on the application, the market is segmented into hospitals & diagnostic centers, life science, pharmaceuticals, academic, and medical and clinical research. Hospitals & diagnostic centers account for the highest share of the nucleic acid extraction system market.

Even genetic disorders such as sickle cell, Tay-Sachs, hemophilia A, and anemia disease can be accurately diagnosed using DNA/RNA extraction procedures. Therefore, it is anticipated that the accessibility of such advanced methods at moderate to low prices will improve the adoption rate of these technologies in hospitals & diagnostic centers.

Technological advancements in areas such as sample preparation and rising demand for new extraction techniques and advanced nucleic acid arrays are driving the demand for nucleic acid extraction systems in hospitals & diagnostic centers.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What is the Competitive Landscape for the Nucleic Acid Extraction System Market?

Key players are working on many projects to increase the number of nucleic acid extraction instruments and kits. To maximize the benefits to end users and speed up research turnaround time, players are investing in discovering and incorporating innovative efficient solutions.

For instance :

  • In 2020, Thermo Fisher acquired QIAGEN N.V., a major global supplier of diagnostic techniques and sample preparation technology. This investment is expected to extend the company’s specialty diagnostics offering with revolutionary sample processing, test, and bioinformatics solutions.

Key Segments Covered in Nucleic Acid Extraction System Industry Research

  • Nucleic Acid Extraction System Market by Product :

    • DNA Extraction
    • RNA Extraction
    • Protein Extraction
  • Nucleic Acid Extraction System Market by Application :

    • Hospitals & Diagnostic Centers
    • Life Science
    • Pharmaceuticals
    • Academic
    • Medical and Clinical Research
  • Nucleic Acid Extraction System Market by Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

- FAQs -

What is the current value of the nucleic acid extraction system market?

In 2022, the global nucleic acid extraction system market stands at US$ 4.63 billion.

Which is a leading country in the market?

China dominates the industry with 15.7% market share.

Which region leads the global market?

Europe leads demand for nucleic acid extraction systems with 28.6% share.

At what CAGR is the market expected to rise?

The global market is predicted to surge at 11.4% CAGR through 2032.

Nucleic Acid Extraction System Market

Schedule a Call